ARCHIVES

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

This article is from The Cancer Letter archive.

Vol. 32 No. 24 | June 23, 2006

Download PDF Visit The Full Archive

Related Articles

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

DCPC Forms Decision Network To oversee Chemoprevention

July 16, 1993

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

September 15, 2006